• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    Healthcare Cold Chain Logistics Market Research Report—Global Forecast till 2032 Infographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Healthcare Cold Chain Logistics Market

    ID: MRFR/HC/5088-CR
    202 Pages
    Rahul Gotadki
    November 2021

    Healthcare Cold Chain Logistics Market Research Report Information By Product (Vaccines, Biopharmaceuticals, Clinical Trial Materials, and Others), By Services (Transportation, Storage, Packaging, Labeling, and Others), By Mode of Delivery (Last-Mile Delivery and Hubs-to-Distributor), By Temperature Range (Ambient, Refrigerated, Frozen, and Cryogenic), By End User (Hospitals & Clinics, Pharmaceutical, Biopharmaceutical, Biotechnology Companies, and Others), And By Region – Market Forecast Till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Healthcare Cold Chain Logistics Market Research Report—Global Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Healthcare Cold Chain Logistics Market Summary

    As per Market Research Future Analysis, the Healthcare Cold Chain Logistics Market was valued at USD 4.5 billion in 2023 and is projected to reach USD 7.66 billion by 2032, growing at a CAGR of 4.60% from 2024 to 2032. Key drivers include the expansion of biopharma distribution networks, increased adoption of automated systems, and a shift towards biosimilars and biologic drugs. The market is characterized by rising transportation of temperature-sensitive pharmaceuticals, necessitating advanced cold chain logistics solutions to maintain product integrity during transport.

    Key Market Trends & Highlights

    The healthcare cold chain logistics market is witnessing significant growth driven by technological advancements and increasing demand for temperature-sensitive products.

    • Vaccines segment contributed ~32-35% to market revenue in 2022.
    • Biopharmaceutical segment expected to grow fastest between 2024 and 2032.
    • Transportation services dominated the market in 2022 and projected to grow rapidly during the forecast period.
    • North America accounted for USD 6.36 billion in 2022, driven by high pharmaceutical and biologic medication demand.

    Market Size & Forecast

    2023 Market Size USD 4.5 Billion
    2032 Market Size USD 7.66 Billion
    CAGR (2024-2032) 4.60%

    Major Players

    Key companies include Cardinal Health, Amerisource Bergen, Envirotainer, Thermoking, FedEx, Sonoco Thermosafe, Phoenix Group, B Medical Systems, Agility, and Dokasch.

    Healthcare Cold Chain Logistics Market Trends

      • Rising transportation of temperature-sensitive pharmaceuticals via cold chain logistics to drive market growth

    The healthcare and pharmaceutical industries are expanding rapidly and developing novel drugs with increased efficacy. It is essential to store and refrigerate these medications properly. This requirement has ushered in a new era of healthcare cold chain logistics. Moreover, pharmaceutical exports are rapidly increasing due to government bodies in several countries focusing on providing advanced healthcare facilities to their citizens. The need for a well-equipped healthcare setup is expected to open new avenues in the market CAGR of healthcare cold chain logistics in the coming years.

    Various temperature levels must be maintained to ensure the integrity of pharmaceutical products throughout the transport chain. The healthcare cold chain logistics industry has developed temperature guidelines to accommodate most products. Logistics for cold storage packaging have evolved. The transportation of temperature-sensitive goods has increased due to market player acquisitions and technological developments in the cold chain logistics sector. This has helped the healthcare cold chain logistics market revenue rise. For example, the Radio Frequency Identification (RFID) system is a promising technological advancement with several advantages for temperature monitoring of pharmaceuticals and other healthcare products.

    The ongoing evolution of healthcare cold chain logistics is crucial for maintaining the integrity of temperature-sensitive products, thereby ensuring patient safety and enhancing the overall efficiency of healthcare delivery systems.

    U.S. Food and Drug Administration (FDA)

    Healthcare Cold Chain Logistics Market Drivers

    Regulatory Compliance

    Regulatory compliance is an essential driver for the Global Healthcare Cold Chain Logistics Market Industry. Governments and health authorities worldwide impose stringent regulations on the transportation and storage of temperature-sensitive products. Compliance with these regulations is critical for maintaining product efficacy and safety. As regulatory frameworks evolve, logistics providers must adapt their operations to meet these requirements, which often necessitates investment in advanced cold chain solutions. This ongoing need for compliance contributes to the market's growth, as companies seek to avoid penalties and ensure the integrity of their products throughout the supply chain.

    Market Growth Projections

    The Global Healthcare Cold Chain Logistics Market Industry is projected to experience substantial growth in the coming years. With a market value of 4.7 USD Billion in 2024, it is anticipated to reach 8.77 USD Billion by 2035. This growth trajectory indicates a robust CAGR of 5.83% from 2025 to 2035. Such projections reflect the increasing importance of cold chain logistics in the healthcare sector, driven by factors such as rising demand for biopharmaceuticals, technological advancements, and regulatory compliance. The market's expansion is likely to create new opportunities for logistics providers and stakeholders in the healthcare supply chain.

    Technological Advancements

    Technological advancements play a crucial role in enhancing the efficiency of the Global Healthcare Cold Chain Logistics Market Industry. Innovations such as IoT-enabled temperature monitoring systems and automated storage solutions are transforming traditional logistics practices. These technologies enable real-time tracking and monitoring of temperature-sensitive products, ensuring compliance with regulatory standards. As logistics providers adopt these advanced technologies, they can reduce waste and improve operational efficiency, which is vital in a market projected to grow from 4.7 USD Billion in 2024 to 8.77 USD Billion by 2035. The integration of technology is likely to be a significant factor in achieving the anticipated CAGR of 5.83% during the 2025-2035 period.

    Globalization of Supply Chains

    The globalization of supply chains significantly influences the Global Healthcare Cold Chain Logistics Market Industry. As pharmaceutical companies expand their operations internationally, the need for reliable cold chain logistics becomes paramount. Global supply chains often involve complex transportation routes that require precise temperature control to ensure product safety. This trend is driving investments in cold chain infrastructure and logistics capabilities, as companies seek to maintain the quality of their products across borders. The increasing interconnectedness of global markets suggests that the demand for cold chain logistics will continue to rise, further propelling market growth.

    Increasing Healthcare Expenditure

    Increasing healthcare expenditure is a notable driver of the Global Healthcare Cold Chain Logistics Market Industry. As countries invest more in healthcare infrastructure and services, the demand for temperature-sensitive medical products rises. This trend is particularly evident in emerging economies, where healthcare spending is on the rise. The growing focus on improving healthcare access and quality is likely to lead to increased investments in cold chain logistics to ensure the safe delivery of vaccines, biologics, and other critical products. This heightened investment in healthcare logistics is expected to contribute to the overall growth of the market.

    Rising Demand for Biopharmaceuticals

    The increasing demand for biopharmaceuticals is a primary driver of the Global Healthcare Cold Chain Logistics Market Industry. As the biopharmaceutical sector expands, the need for temperature-sensitive products, such as vaccines and biologics, intensifies. In 2024, the market is valued at approximately 4.7 USD Billion, reflecting the growing reliance on cold chain logistics to maintain product integrity. The stringent storage and transportation requirements for these products necessitate advanced cold chain solutions, which are expected to evolve further. This trend suggests that the market will continue to grow, potentially reaching 8.77 USD Billion by 2035, with a CAGR of 5.83% from 2025 to 2035.

    Market Segment Insights

    Healthcare Cold Chain Logistics Product Insights

    The Market segmentation of Healthcare Cold Chain Logistics, based on product, includes vaccines, biopharmaceuticals, clinical trial materials, and others. The vaccines segment held the majority share in 2022, contributing around ~32-35% to the Market revenue of Healthcare Cold Chain Logistics. Vaccines are a vital class of pharmaceuticals with high global demand. Vaccines typically necessitate temperature control, which is obtained through cold chains. Furthermore, pharmaceutical industries are primarily concerned with product responsiveness and quality. Increased production of complex proteins, hormone treatments, vaccines, and other biologically based medicines commonly require a cold chain infrastructure.

    Figure 2: Healthcare Cold Chain Logistics Market, by Product, 2022 & 2030 (USD Billion)

    Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

    Further, the biopharmaceutical segment is expected to grow fastest between 2024 and 2032. The biopharmaceutical healthcare cold chain logistics market is expanding due to increasing demand for temperature-controlled logistics services and biopharmaceutical companies expanding distribution networks to increase sales and transport biologics in various geographical areas. The rising popularity of targeted therapies and increased investment in the global healthcare sector creates opportunities for biopharmaceutical products.

    Healthcare Cold Chain Logistics Services Insights

    The Healthcare Cold Chain Logistics Market segmentation, based on services, includes transportation, storage, packaging, labeling, and others. The transportation segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2024-2032, due to the increased utilization of safe, temperature-controlled transportation of temperature-sensitive products and services. In healthcare cold chain logistics, transportation services play a crucial role. The need for specialized temperature-controlled systems throughout transport on ships, trucks, and airplanes has resulted in very high demand for cold-chain transportation services.

    Healthcare Cold Chain Logistics Mode of Delivery Insights

    The Healthcare Cold Chain Logistics Market data has been bifurcated by mode of delivery into last-mile delivery and hubs-to-distributor. The hubs-to-distributor segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period 2024-2032. This is due to the administration of co-pay assistance programs, which remove financial barriers between patients and the vaccines invented by manufacturers and recommended by providers in the healthcare sector.

    Healthcare Cold Chain Logistics Temperature Range Insights

    The global healthcare cold chain logistics industry has been segmented based on temperature range into ambient, refrigerated, frozen, and cryogenic. Refrigerated held the most prominent segment share in 2022. A refrigerator is primarily used to keep medications cold. Low temperatures allow the mixture to remain efficient for a more extended period. The main goal of refrigeration is to reduce the contamination rate such that it takes longer for bacteria to contaminate and spoil the medications.

    Healthcare Cold Chain Logistics End User Insights

    Based on end users, the global healthcare cold chain logistics industry has been segmented into hospitals & clinics, pharmaceuticals, biopharmaceuticals, biotechnology companies, and others. Pharmaceuticals held the highest segment revenue share in 2022, owing to the increasing implementation of cold chain logistics by multinational pharmaceutical companies, which have a global distribution network and require cold chain solutions to preserve this network and meet the demand for products needed in various countries.

    According to the FDA, global spending on pharmaceutical research and development was valued at USD 184 billion in 2018 and is expected to rise to USD 238 billion by 2021. As a result, high-quality cold chain logistics are required to deliver quality medicines to hospitals. Furthermore, increasing pharmaceutical company investments in drug discovery has improved market growth affordability for healthcare cold chain logistics services.

    Get more detailed insights about Healthcare Cold Chain Logistics Market Research Report—Global Forecast till 2032

    Request Free Sample

    Regional Insights

    By Region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Healthcare Cold Chain Logistics market accounted for USD 6.36 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. This high revenue share is primarily due to the region's dominance in pharmaceutical and biologic medications and an increase in biopharmaceutical exports and imports. The region's high healthcare cost contributes to the relatively high adoption of new technologies.

    As a result, healthcare companies with North American operations increasingly rely on healthcare cold chain logistics service providers to optimize warehousing and transportation, fueling regional growth. Another factor contributing to this regional segment's dominance is the presence of prominent regional firms.

    Further, the major countries studied in the market report are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 3: Healthcare Cold Chain Logistics Market Share By Region 2022 (%)HEALTHCARE COLD CHAIN LOGISTICS MARKET SHARE BY REGION 2022 (%)

    Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

    European healthcare cold chain logistics market accounts for the second-largest market share. Numerous US-based businesses are extending their services in the region in response to the rising demand for European pharmaceutical shipping. For instance, Delta Cargo applied for the CEIV Pharma certification mark for its headquarters and the largest hub in Atlanta, Georgia. It became the first US-based international passenger carrier to receive it in August 2019. This enables Delta Cargo to link shipments from Atlanta to the European cities of Amsterdam, Brussels, Milan, Paris, and Rome that are CEIV Pharma-certified.

    Further, the German market of healthcare cold chain logistics held the largest market share, and the UK market of healthcare cold chain logistics was the fastest-growing market in the European region.

    The Asia-Pacific Healthcare Cold Chain Logistics Market is expected to grow at the fastest CAGR between 2024 and 2032, owing to rising demand for cold storage facilities, increased adoption of technologically advanced facilities, and increased merger and acquisition activity by industry players. In February 2021, for example, Asian global logistics Apex International Company was acquired by Kuehne+Nagel, one of the leading logistics firms specializing in integrated market of healthcare cold chain logistics services. The primary goal of this acquisition is to help the company provide a compelling offering to customers, particularly in e-commerce fulfillment, advanced tech, and e-mobility.

    Moreover, the China market of healthcare cold chain logistics held the largest market share, and the Indian market of healthcare cold chain logistics was the fastest-growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Major market players in the healthcare cold chain logistics industry are concentrating on offering technologically cutting-edge logistics solutions to improve their competitiveness in the international market. Competitors in the healthcare cold chain logistics industry are incorporating next-generation logistics solution technologies such as automated processes, artificial intelligence (AI) & machine learning (ML), blockchain, transport management systems, and others into their services to increase supply chain productivity, reduce costs, and avoid errors.

    The market for healthcare cold chain logistics is highly fragmented due to increasing competition, product launches, joint ventures, and other strategic market developments and decisions to improve operational effectiveness. The healthcare cold chain logistics market’s major players compete based on product cost, quality, timely availability, and dependability. It is decisive for the players to provide cost-efficient products to survive and succeed in an increasingly competitive and growing healthcare cold chain logistics industry environment.

    DoKaSch offers advanced climate control options for the international air transportation of temperature-sensitive cargo. They protect the effectiveness of essential pharmaceuticals, for instance, throughout long-distance transportation chains. Their Icecooler, Unicooler, and Opticooler products are renowned for their exceptional dependability. Their containers ensure that vital medications are delivered to patients worldwide in perfect condition. Dokasch (Germany) introduced a brand-new high-tech cooler for vaccine transportation in November 2020. This product safeguards pharmacological vaccines and drugs against high temperatures.

    Also, Sonoco ThermoSafe, a Sonoco division, is a global leader in temperature assurance packaging for the safe and efficient transportation of pharmaceuticals, vaccines, biologics, and other temperature-sensitive products. Sonoco ThermoSafe (US) obtained FAA approval for the Pegasus ULD with high-volume temperature control for pharmacological use in September 2020.

    Key Companies in the Healthcare Cold Chain Logistics Market market include

    Industry Developments

    January 2021: Varcode has collaborated with PL Development. The partnerships are expected to improve supply cold chain logistics efficiency, particularly in the healthcare sector.

    December 2020: FedEx Corp. purchased ShopRunner. The acquisition will improve e-commerce capabilities by providing the cost-effective healthcare cold chain logistics required to provide biopharmaceutical products on time.

    March 2020: CEVA Logistics has introduced a new healthcare sub-brand called CEVA FORPATIENTS. The cold chain logistics under this brand will only be used for medical needs, including the delivery of medications and the transfer of organs.

    Future Outlook

    Healthcare Cold Chain Logistics Market Future Outlook

    The Healthcare Cold Chain Logistics Market is projected to grow at a 5.83% CAGR from 2024 to 2035, driven by technological advancements, regulatory compliance, and increasing demand for temperature-sensitive products.

    New opportunities lie in:

    • Invest in IoT-enabled tracking systems to enhance supply chain visibility and efficiency.
    • Develop sustainable packaging solutions to meet environmental regulations and consumer preferences.
    • Expand partnerships with pharmaceutical companies to streamline distribution of biologics and vaccines.

    By 2035, the market is expected to achieve robust growth, reflecting evolving healthcare logistics demands.

    Market Segmentation

    Healthcare Cold Chain Logistics Product Outlook

    • Vaccines
    • Biopharmaceuticals
    • Clinical Trial Materials
    • Others

    Healthcare Cold Chain Logistics End User Outlook

    • Hospitals & Clinics
    • Pharmaceutical
    • Biopharmaceutical
    • Biotechnology Companies
    • Others

    Healthcare Cold Chain Logistics Regional Outlook

    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America

    Healthcare Cold Chain Logistics Services Outlook

    • Transportation
    • Storage
    • Packaging
    • Labeling
    • Others

    Healthcare Cold Chain Logistics Mode of Delivery Outlook

    • Last-Mile Delivery
    • Hubs-to-Distributor

    Healthcare Cold Chain Logistics Temperature Range Outlook

    • Ambient
    • Refrigerated
    • Frozen
    • Cryogenic

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 USD 4.5 billion
    Market Size 2024 USD 4.7 billion
    Market Size 2032 USD 7.66 billion
    Compound Annual Growth Rate (CAGR) 4.6% (2024-2032)
    Base Year 2023
    Market Forecast Period 2024-2032
    Historical Data 2018 - 2022
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product, Services, Mode of Delivery, Temperature Range, End User, and Region
    Geographies Covered Europe, North America, Asia Pacific, and the Rest of the World
    Countries Covered The U.S, Germany, Canada, U.K., Italy, France, Spain, Japan, China, Australia, India, South Korea, and Brazil
    Key Companies Profiled Cardinal Health, Amerisource Bergen, Envirotainer, Thermoking, FedEx, Sonoco Thermosafe, Phoenix Group, B Medical Systems, Agility, Dokasch
    Key Market Opportunities A growing number of healthcare clinical trials across the globe Emerging technological advancements in healthcare cold chain logistics
    Key Market Dynamics Increased transportation of temperature-sensitive pharmaceutical products via cold-chain logistics Rising demands for biopharmaceutical products

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    How much is the healthcare cold chain logistics market?

    The Healthcare Cold Chain Logistics Market size was valued at USD 4.5 Billion in 2023.

    What is the growth rate of the healthcare cold chain logistics market?

    The global market is projected to grow at a CAGR of 4.6% during the forecast period, 2024-2032.

    Which region held the largest market share in the healthcare cold chain logistics market?

    North America had the largest share of the global market.

    Who are the key players in the healthcare cold chain logistics market?

    The key players in the market are Cardinal Health, Amerisource Bergen, Envirotainer, Thermoking, FedEx, Sonoco Thermosafe, Phoenix Group, B Medical Systems, Agility, and Dokasch.

    Which product led the healthcare cold chain logistics market?

    The vaccines category dominated the market in 2022.

    Which services had the largest market share in the healthcare cold chain logistics market?

    Transportation had the largest revenue share of the global market.

    1. 'TABLE OF CONTENTS
    2. EXECUTIVE SUMMARY
    3. MARKET INTRODUCTION
      1. SCOPE OF THE STUDY
      2. SCOPE OF THE STUDY
      3. RESEARCH OBJECTIVE
      4. MARKET STRUCTURE
      5. ASSUMPTIONS &
    4. LIMITATIONS
    5. RESEARCH METHODOLOGY
    6. DATA MINING
    7. SECONDARY RESEARCH
    8. PRIMARY RESEARCH
    9. BREAKDOWN OF PRIMARY RESPONDENTS
      1. FORECASTING TECHNIQUES
      2. RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
        1. BOTTOM-UP APPROACH
        2. TOP-DOWN APPROACH
      3. DATA TRIANGULATION
      4. VALIDATION
    10. MARKET DYNAMICS
      1. OVERVIEW
      2. DRIVERS
        1. GROWING TRANSPORTATION
    11. OF TEMPERATURE-SENSITIVE PHARMACEUTICAL PRODUCTS VIA COLD CHAIN LOGISTICS
      1. GROWING DEMAND
    12. FOR BIOPHARMACEUTICAL PRODUCTS
      1. INCREASING NUMBER OF CLINICAL TRIALS
      2. RESTRAINTS
        1. DIFFICULTY TO ACCESS DIFFERENT MARKETS
        2. FAILURE TO COMPLY
    13. WITH THE REGULATORY STANDARDS
      1. OPPORTUNITIES
        1. TECHNOLOGICAL ADVANCEMENTS IN COLD CHAIN LOGISTICS
        2. DEVELOPMENT OF
    14. NEW THERAPIES
    15. MARKET FACTOR ANALYSIS
    16. VALUE CHAIN ANALYSIS
    17. PORTER’S FIVE FORCES MODEL
      1. BARGAINING POWER OF SUPPLIERS
        1. BARGAINING POWER OF BUYERS
        2. THREAT OF NEW ENTRANTS
        3. THREAT OF SUBSTITUTES
        4. RIVALRY
      2. IMPACT OF COVID-19
    18. ON THE GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET
      1. IMPACT ON PRICING
        1. IMPACT ON DEMAND AND SUPPLY
        2. IMPACT ON GOVERNMENT RULES
        3. IMPACT ON KEY PLAYERS
    19. GLOBAL HEALTHCARE COLD
    20. CHAIN LOGISTICS MARKET, BY PRODUCT
      1. OVERVIEW
      2. VACCINES
      3. BIOPHARMACEUTICALS
      4. CLINICAL TRIAL MATERIALS
      5. OTHERS
    21. GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET,
    22. BY SERVICES
    23. OVERVIEW
    24. TRANSPORTATION
    25. STORAGE
    26. PACKAGING
    27. LABELLING
    28. OTHERS
    29. GLOBAL
    30. HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY MODE OF DELIVERY
      1. OVERVIEW
      2. LAST-MILE DELIVERY
      3. HUBS-TO-DISTRIBUTOR
    31. GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET,
    32. BY TEMPERATURE RANGE
    33. OVERVIEW
    34. AMBIENT
    35. REFRIGERATED
    36. FROZEN
    37. CRYOGENIC
    38. GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY STORAGE TECHNIQUES RANGE
      1. OVERVIEW
      2. ELECTRICAL REFRIGRATION
      3. DRY ICE
      4. GEL PACKS
      5. LIQUID NITROGEN
      6. OTHERS
    39. GLOBAL HEALTHCARE
    40. COLD CHAIN LOGISTICS MARKET, BY END USER
      1. OVERVIEW
      2. HOSPITAL AND CLINICS
      3. PHARMACEUTICAL, BIOPHARMACEUTICAL, AND BIOTECHNOLOGY
    41. COMPANIES
    42. OTHERS
    43. GLOBAL
    44. HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY REGION
      1. OVERVIEW
      2. AMERICAS
        1. NORTH AMERICA
        2. LATIN AMERICA
      3. EUROPE
        1. WESTERN EUROPE
        2. EASTERN EUROPE
      4. ASIA-PACIFIC
        1. CHINA
        2. INDIA
        3. JAPAN
        4. SOUTH KOREA
        5. AUSTRALIA
        6. REST OF ASIA-PACIFIC
      5. MIDDLE EAST & AFRICA
        1. MIDDLE EAST
        2. AFRICA
    45. COMPETITIVE LANDSCAPE
      1. OVERVIEW
      2. MARKET SHARE ANALYSIS
      3. COMPETITIVE BENCHMARKING
      4. MAJOR GROWTH STRATEGY IN THE GLOBAL HEALTHCARE
    46. COLD CHAIN LOGISTICS MARKET
      1. THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL
    47. HEALTHCARE COLD CHAIN LOGISTICS MARKET
      1. KEY DEVELOPMENT ANALYSIS
      2. KEY DEVELOPMENTS & GROWTH STRATEGIES
        1. PRODUCT LAUNCH/PRODUCT
    48. APPROVAL
    49. PARTNERSHIP/AGREEMENT
    50. ACQUISITIONS
    51. EXPANSION
    52. COMPANY PROFILE
    53. CARDINAL HEALTH
    54. COMPANY OVERVIEW
    55. FINANCIAL OVERVIEW
    56. PRODUCTS/SERVICES OFFERED
      1. KEY DEVELOPMENTS
        1. SWOT ANALYSIS
        2. KEY STRATEGIES
      2. WALDEN GROUP
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      3. OMEGA LOGISTICS
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES
    57. OFFERED
    58. KEY DEVELOPMENTS
    59. SWOT ANALYSIS
    60. KEY STRATEGIES
    61. FIEGE
    62. COMPANY OVERVIEW
    63. FINANCIAL OVERVIEW
    64. PRODUCTS/SERVICES OFFERED
      1. KEY DEVELOPMENTS
        1. SWOT ANALYSIS
        2. KEY STRATEGIES
      2. COLDTAINER
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      3. ALMAC GROUP
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES
    65. OFFERED
    66. KEY DEVELOPMENTS
    67. SWOT ANALYSIS
    68. KEY STRATEGIES
    69. AMERISOURCE BERGEN CORPORATION
      1. COMPANY OVERVIEW
        1. FINANCIAL OVERVIEW
        2. PRODUCTS/SERVICES OFFERED
        3. KEY DEVELOPMENTS
        4. SWOT ANALYSIS
        5. KEY STRATEGIES
      2. COLDMAN LOGISTICS
    70. PVT LTD
    71. COMPANY OVERVIEW
    72. FINANCIAL OVERVIEW
    73. PRODUCTS/SERVICES OFFERED
      1. KEY DEVELOPMENTS
        1. SWOT ANALYSIS
        2. KEY STRATEGIES
      2. THERMOKING (TRANE TECHNOLOGIES)
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES
    74. OFFERED
    75. KEY DEVELOPMENTS
    76. SWOT ANALYSIS
    77. KEY STRATEGIES
    78. CAVALIER LOGISTICS
    79. COMPANY OVERVIEW
    80. FINANCIAL OVERVIEW
    81. PRODUCTS/SERVICES OFFERED
      1. KEY DEVELOPMENTS
        1. SWOT ANALYSIS
        2. KEY STRATEGIES
      2. FEDEX
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      3. ENVIROTAINER
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES
    82. OFFERED
    83. KEY DEVELOPMENTS
    84. SWOT ANALYSIS
    85. KEY STRATEGIES
    86. DOKASCH
    87. COMPANY OVERVIEW
    88. FINANCIAL OVERVIEW
    89. PRODUCTS/SERVICES OFFERED
      1. KEY DEVELOPMENTS
        1. SWOT ANALYSIS
        2. KEY STRATEGIES
      2. B MEDICAL SYSTEMS
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      3. SONOCO THERMOSAFE
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES
    90. OFFERED
    91. KEY DEVELOPMENTS
    92. SWOT ANALYSIS
    93. KEY STRATEGIES
    94. LEC MEDICAL
    95. COMPANY OVERVIEW
    96. FINANCIAL OVERVIEW
    97. PRODUCTS/SERVICES OFFERED
      1. KEY DEVELOPMENTS
        1. SWOT ANALYSIS
        2. KEY STRATEGIES
      2. STIRLING ULTRACOLD
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      3. VRR
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES
    98. OFFERED
    99. KEY DEVELOPMENTS
    100. SWOT ANALYSIS
    101. KEY STRATEGIES
    102. PHOENIX GROUP
    103. COMPANY OVERVIEW
    104. FINANCIAL OVERVIEW
    105. PRODUCTS/SERVICES OFFERED
      1. KEY DEVELOPMENTS
        1. SWOT ANALYSIS
        2. KEY STRATEGIES
      2. AGILITY
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
    106. APPENDIX
      1. REFERENCES
      2. RELATED REPORTS
    107. & LIMITATIONS
    108. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
    109. BY PRODUCT, 2023–2030 (USD MILLION)
    110. FOR VACCINES, BY REGION, 2023–2030 (USD MILLION)
    111. FOR BIOPHARMACEUTICALS, BY REGION, 2023–2030 (USD MILLION)
    112. CHAIN LOGISTICS MARKET, FOR CLINICAL TRIAL MATERIALS, BY REGION, 2023–2030
    113. (USD MILLION)
    114. GLOBAL: HEALTHCARE COLD CHAIN LOGISTICS MARKET, FOR OTHERS, BY REGION, 2023–2030
    115. (USD MILLION)
    116. GLOBAL: HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY SERVICES, 2023–2030 (USD
    117. MILLION)
    118. GLOBAL: HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY TRANSPORTATION, 2023–2030
    119. (USD MILLION), BY REGION, 2023–2030 (USD MILLION)
    120. MARKET, BY STORAGE, 2023–2030 (USD MILLION), BY REGION, 2023–2030 (USD
    121. MILLION)
    122. GLOBAL: HEALTHCARE COLD CHAIN LOGISTICS MARKET, FOR STORAGE, BY TYPE, 2023–2030
    123. (USD MILLION)
    124. GLOBAL: HEALTHCARE COLD CHAIN LOGISTICS MARKET, FOR COMPRESSOR COOLED EQUIPMENT,
    125. BY TYPE, 2023–2030 (USD MILLION)
    126. BY PACKAGING, 2023–2030 (USD MILLION), BY REGION, 2023–2030 (USD MILLION)
    127. COLD CHAIN LOGISTICS MARKET, BY LABELLING, 2023–2030 (USD MILLION), BY REGION,
    128. –2030 (USD MILLION)
    129. –2030 (USD MILLION), BY REGION, 2023–2030 (USD MILLION)
    130. COLD CHAIN LOGISTICS MARKET, BY MODE OF DELIVERY, 2023–2030 (USD MILLION)
    131. COLD CHAIN LOGISTICS MARKET, BY LAST-MILE DELIVERY, 2023–2030 (USD MILLION),
    132. BY REGION, 2023–2030 (USD MILLION)
    133. BY HUBS-TO-DISTRIBUTOR, 2023–2030 (USD MILLION), BY REGION, 2023–2030
    134. (USD MILLION)
    135. GLOBAL: HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE RANGE, 2023–2030
    136. (USD MILLION)
    137. GLOBAL: HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY AMBIENT, 2023–2030 (USD
    138. MILLION), BY REGION, 2023–2030 (USD MILLION)
    139. MARKET, BY REFRIGERATED, 2023–2030 (USD MILLION), BY REGION, 2023–2030
    140. (USD MILLION)
    141. GLOBAL: HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY FROZEN, 2023–2030 (USD
    142. MILLION), BY REGION, 2023–2030 (USD MILLION)
    143. MARKET, BY CRYOGENIC, 2023–2030 (USD MILLION), BY REGION, 2023–2030
    144. (USD MILLION)
    145. GLOBAL: HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY STORAGE TECHNIQUES, 2023–2030
    146. (USD MILLION)
    147. GLOBAL: HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY ELECTRICAL REFRIGERATION,
    148. –2030 (USD MILLION), BY REGION, 2023–2030 (USD MILLION)
    149. COLD CHAIN LOGISTICS MARKET, BY DRY ICE, 2023–2030 (USD MILLION), BY REGION,
    150. –2030 (USD MILLION)
    151. –2030 (USD MILLION), BY REGION, 2023–2030 (USD MILLION)
    152. COLD CHAIN LOGISTICS MARKET, BY LIQUID NITROGEN, 2023–2030 (USD MILLION),
    153. BY REGION, 2023–2030 (USD MILLION)
    154. BY OTHERS, 2023–2030 (USD MILLION), BY REGION, 2023–2030 (USD MILLION)
    155. COLD CHAIN LOGISTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
    156. COLD CHAIN LOGISTICS MARKET, BY HOSPITAL AND CLINICS, 2023–2030 (USD MILLION),
    157. BY REGION, 2023–2030 (USD MILLION)
    158. BY PHARMACEUTICAL, BIOPHARMACEUTICAL, AND BIOTECHNOLOGY COMPANIES, 2023–2030
    159. (USD MILLION), BY REGION, 2023–2030 (USD MILLION)
    160. MARKET, BY OTHERS, 2023–2030 (USD MILLION), BY REGION, 2023–2030 (USD
    161. MILLION)
    162. GLOBAL: HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY REGION, 2023–2030 (USD
    163. MILLION)
    164. AMERICAS HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY REGION, 2023–2030 (USD
    165. MILLION)
    166. AMERICAS HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2023–2030
    167. (USD MILLION)
    168. AMERICAS HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY SERVICES, 2023–2030
    169. (USD MILLION)
    170. AMERICAS HEALTHCARE COLD CHAIN LOGISTICS MARKET, FOR STORAGE, BY TYPE, 2023–2030
    171. (USD MILLION)
    172. AMERICAS HEALTHCARE COLD CHAIN LOGISTICS MARKET, FOR COMPRESSOR COOLED EQUIPMENT,
    173. BY TYPE, 2023–2030 (USD MILLION)
    174. BY MODE OF DELIVERY, 2023–2030 (USD MILLION)
    176. arial, helvetica, s'

    Healthcare Cold Chain Logistics Market Segmentation 

    Healthcare Cold Chain Logistics Mode of Delivery Outlook (USD Billion, 2018-2030)

    • Last-Mile Delivery
    • Hubs-to-Distributor

    Healthcare Cold Chain Logistics Product Outlook (USD Billion, 2018-2030)

    • Vaccines
    • Biopharmaceuticals
    • Clinical Trial Materials

    Healthcare Cold Chain Logistics Services Outlook (USD Billion, 2018-2030)

    • Transportation
    • Storage
    • Packaging
    • Labeling
    • Others

    Healthcare Cold Chain Logistics End User Outlook (USD Billion, 2018-2030)

    • Hospitals & Clinics
    • Pharmaceutical
    • Biopharmaceutical
    • Biotechnology Companies
    • Others

    Healthcare Cold Chain Logistics Temperature Range Outlook (USD Billion, 2018-2030)

    • Ambient
    • Refrigerated
    • Frozen
    • Cryogenic

    Healthcare Cold Chain Logistics Regional Outlook (USD Billion, 2018-2030)

    • North America Outlook (USD Billion, 2018-2030)
      • North America Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • North America Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • North America Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • North America Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • North America Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • US Outlook (USD Billion, 2018-2030)
      • US Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • US Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • US Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • US Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • US Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • CANADA Outlook (USD Billion, 2018-2030)
      • CANADA Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • CANADA Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • CANADA Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • CANADA Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • CANADA Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
    • Europe Outlook (USD Billion, 2018-2030)
      • Europe Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • Europe Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • Europe Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • Europe Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • Europe Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • Germany Outlook (USD Billion, 2018-2030)
      • Germany Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • Germany Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • Germany Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • Germany Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • Germany Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • France Outlook (USD Billion, 2018-2030)
      • France Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • France Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • France Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • France Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • France Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • UK Outlook (USD Billion, 2018-2030)
      • UK Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • UK Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • UK Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • UK Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • UK Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • ITALY Outlook (USD Billion, 2018-2030)
      • ITALY Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • ITALY Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • ITALY Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • ITALY Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • ITALY Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • SPAIN Outlook (USD Billion, 2018-2030)
      • Spain Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • Spain Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • Spain Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • Spain Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • Spain Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • Rest Of Europe Outlook (USD Billion, 2018-2030)
      • Rest Of Europe Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • REST OF EUROPE Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • REST OF EUROPE Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • REST OF EUROPE Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • REST OF EUROPE Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
    • Asia-Pacific Outlook (USD Billion, 2018-2030)
      • Asia-Pacific Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • Asia-Pacific Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • Asia-Pacific Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • Asia-Pacific Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • Asia-Pacific Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • China Outlook (USD Billion, 2018-2030)
      • China Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • China Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • China Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • China Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • China Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • Japan Outlook (USD Billion, 2018-2030)
      • Japan Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • Japan Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • Japan Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • Japan Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • Japan Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • India Outlook (USD Billion, 2018-2030)
      • India Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • India Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • India Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • India Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • India Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • Australia Outlook (USD Billion, 2018-2030)
      • Australia Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • Australia Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • Australia Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • Australia Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • Australia Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)
      • Rest of Asia-Pacific Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • Rest of Asia-Pacific Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • Rest of Asia-Pacific Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • Rest of Asia-Pacific Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • Rest of Asia-Pacific Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
    • Rest of the World Outlook (USD Billion, 2018-2030)
      • Rest of the World Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • Rest of the World Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • Rest of the World Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • Rest of the World Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • Rest of the World Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • Middle East Outlook (USD Billion, 2018-2030)
      • Middle East Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • Middle East Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • Middle East Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • Middle East Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • Middle East Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • Africa Outlook (USD Billion, 2018-2030)
      • Africa Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • Africa Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • Africa Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • Africa Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • Africa Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
      • Latin America Outlook (USD Billion, 2018-2030)
      • Latin America Healthcare Cold Chain Logistics by Mode of Delivery
        • Last-Mile Delivery
        • Hubs-to-Distributor
      • Latin America Healthcare Cold Chain Logistics by Product
        • Vaccines
        • Biopharmaceuticals
        • Clinical Trial Materials
      • Latin America Healthcare Cold Chain Logistics by Services
        • Transportation
        • Storage
        • Packaging
        • Labeling
        • Others
      • Latin America Healthcare Cold Chain Logistics by End User
        • Hospitals & Clinics
        • Pharmaceutical
        • Biopharmaceutical
        • Biotechnology Companies
        • Others
      • Latin America Healthcare Cold Chain Logistics by Temperature Range
        • Ambient
        • Refrigerated
        • Frozen
        • Cryogenic
    Healthcare Cold Chain Logistics Market Research Report—Global Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027